These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18800145)

  • 21. [Angiogenesis in different clinical phases of chronic myeloid leukemia].
    Krasowska-Kwiecień A; Kijowski J; Łukasiewicz E; Sacha T; Foryciarz K; Majka M; Ratajczak MZ; Skotnicki AB
    Przegl Lek; 2009; 66(9):471-8. PubMed ID: 21033405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
    Padró T; Bieker R; Ruiz S; Steins M; Retzlaff S; Bürger H; Büchner T; Kessler T; Herrera F; Kienast J; Müller-Tidow C; Serve H; Berdel WE; Mesters RM
    Leukemia; 2002 Jul; 16(7):1302-10. PubMed ID: 12094254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenesis, angiogenic factor expression and hematological malignancies.
    Ribatti D; Vacca A; De Falco G; Roccaro A; Roncali L; Dammacco F
    Anticancer Res; 2001; 21(6B):4333-9. PubMed ID: 11908688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors.
    Rana C; Sharma S; Agrawal V; Singh U
    Ann Hematol; 2010 Aug; 89(8):789-94. PubMed ID: 20177896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status.
    Medinger M; Skoda R; Gratwohl A; Theocharides A; Buser A; Heim D; Dirnhofer S; Tichelli A; Tzankov A
    Br J Haematol; 2009 Jul; 146(2):150-7. PubMed ID: 19466975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiangiogenesis in haematological malignancies.
    Li WW; Hutnik M; Gehr G
    Br J Haematol; 2008 Dec; 143(5):622-31. PubMed ID: 19036013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents.
    Cibeira MT; Rozman M; Segarra M; Lozano E; Rosiñol L; Cid MC; Filella X; Bladé J
    Cytokine; 2008 Mar; 41(3):244-53. PubMed ID: 18178097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
    Zou WR; Liu T; Meng WT; Yu J; Niu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
    Ribas C; Colleoni GW; Silva MR; Carregoza MJ; Bordin JO
    Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased angiogenesis-associated poor outcome in acute lymphoblastic leukemia: a single center study.
    Todorovic M; Radisavljevic Z; Balint B; Andjelic B; Todorovic V; Jovanovic MP; Mihaljevic B
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):488-93. PubMed ID: 22417860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant.
    Sucak GT; Aki SZ; Yüzbaşioğlu B; Akyürek N; Yağci M; Bağriaçik U; Haznedar R
    Leuk Lymphoma; 2011 Jul; 52(7):1281-9. PubMed ID: 21599578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Change of vascular endothelial growth factor and its receptors expression in acute myeloid leukemia before and after treatment].
    Zhang JQ; Wang JK; Li YM
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):100-2. PubMed ID: 14990052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density.
    Alexandrakis MG; Passam FH; Pappa CA; Damilakis J; Tsirakis G; Kandidaki E; Passam AM; Stathopoulos EN; Kyriakou DS
    Int J Immunopathol Pharmacol; 2005; 18(2):287-95. PubMed ID: 15888251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
    Shang ZJ; Li JR
    J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
    Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
    Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis and the role of bone marrow endothelial cells in haematological malignancies.
    De Raeve H; Van Marck E; Van Camp B; Vanderkerken K
    Histol Histopathol; 2004 Jul; 19(3):935-50. PubMed ID: 15168356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.
    Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Lung Cancer; 2005 Dec; 50(3):309-17. PubMed ID: 16125276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
    Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
    Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis in hematologic malignancies.
    Moehler TM; Neben K; Ho AD; Goldschmidt H
    Ann Hematol; 2001 Dec; 80(12):695-705. PubMed ID: 11797109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.